EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

The association between the gut microbiota metabolite trimethylamine N-oxide and heart failure

Zharkyn Jarmukhanov, Nurislam Mukhanbetzhanov, Samat Kozhakhmetov, Madiyar Nurgaziyev, Aliya Sailybayeva, Makhabbat Bekbossynova, Almagul Kushugulova

Frontiers in Microbiology · 26.09.2024 · 15

DOI: 10.3389/fmicb.2024.1440241 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Frontiers in Microbiology, online erschienen am 26.09.2024. Verfasst von Zharkyn Jarmukhanov und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Microbiome, Center for Life Sciences, National Laboratory Astana, Nazarbayev University, Astana, Kazakhstan. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This systematic review explores the relationship between the gut microbiota metabolite trimethylamine N-oxide (TMAO) and heart failure (HF), given the significant impact of TMAO on cardiovascular health. A systematic search and meta-analysis of peer-reviewed studies published from 2013 to 2024 were conducted, focusing on adult patients with heart failure and healthy controls. The review found that elevated levels of TMAO are associated with atherosclerosis, endothelial dysfunction, and increased cardiovascular disease risk, all of which can exacerbate heart failure. The analysis also highlights that high TMAO levels are linked to reduced left ventricular ejection fraction (LVEF) and glomerular filtration rate (GFR), further supporting TMAO’s role as a biomarker in heart failure assessment. The findings suggest that interventions targeting gut microbiota to reduce TMAO could potentially benefit patients with heart failure, although further research is needed to evaluate the effectiveness of such approaches.

Schlagwörter

Stichwörter der Autor:innen

TMAOchronic heart failuregut microbiomeheart failuremetabolite

Autor:innen und Institutionen

  • Laboratory of Microbiome, Center for Life Sciences, National Laboratory Astana, Nazarbayev University, Astana, Kazakhstan.
  • Heart Center, CF "University Medical Center", Astana, Kazakhstan.

Zitieren

APA

Jarmukhanov, Z., Mukhanbetzhanov, N., Kozhakhmetov, S., Nurgaziyev, M., Sailybayeva, A., Bekbossynova, M., & Kushugulova, A. (2024). The association between the gut microbiota metabolite trimethylamine N-oxide and heart failure. Frontiers in Microbiology, 15. https://doi.org/10.3389/fmicb.2024.1440241

Vancouver

Jarmukhanov Z, Mukhanbetzhanov N, Kozhakhmetov S, Nurgaziyev M, Sailybayeva A, Bekbossynova M, et al. The association between the gut microbiota metabolite trimethylamine N-oxide and heart failure. Frontiers in Microbiology. 2024;15. doi:10.3389/fmicb.2024.1440241

BibTeX
@article{Jarmukhanov2024,
  author = {Jarmukhanov, Zharkyn and Mukhanbetzhanov, Nurislam and Kozhakhmetov, Samat and Nurgaziyev, Madiyar and Sailybayeva, Aliya and Bekbossynova, Makhabbat and Kushugulova, Almagul},
  title = {The association between the gut microbiota metabolite trimethylamine N-oxide and heart failure},
  journal = {Frontiers in Microbiology},
  year = {2024},
  volume = {15},
  doi = {10.3389/fmicb.2024.1440241}
}
Kostenlos starten →